by Jason Heaviland | Oct 29, 2025
Advancing Animal Model Research with Multi-Omics Integration Discover how Panome Bio’s Next-Generation MetabolomicsTM and integrated multi-omics approaches enhance the translational value of animal model research. This application note demonstrates how comprehensive...
by Jason Heaviland | Sep 24, 2025 | Uncategorized
The Lipid Connection in Neurodegeneration While much of Alzheimer’s disease research has historically focused on protein aggregation (amyloid-beta plaques and tau tangles), a growing body of evidence points to fundamental disruptions in lipid metabolism as both...
by Jason Heaviland | Sep 16, 2025 | Uncategorized
Why Protein-Centric Alzheimer’s Research Has Fallen Short The pharmaceutical industry’s intensive focus on amyloid-beta and tau pathology in Alzheimer’s disease has yielded limited therapeutic success despite decades of investment and dozens of clinical...
by ODWAdmin | Sep 6, 2024
Next-Generation Metabolomics Reveal Pathway Dysregulation Consistent with Alzheimer’s Disease in Apolipoprotein E Knockout Rats Panome Bio’s Next-Generation Metabolomics® platform provides an unbiased and global view of metabolism. In this poster, the metabolic...
by ODWAdmin | Sep 7, 2023
Global metabolomics, when applied to Parkinson’s Disease research, has the potential to make a significant impact in biomarker development, whether for susceptibility, diagnosis, pharmacodynamic response or prognostic assessment of disease. And even beyond biomarkers,...
